CClinicalTrials.gg
Status unknownNCT03728270Updated Nov 2, 2018

Assessment of Maximal Incisal Opening Using Patient Specific Titanium Eminoplasty Versus Inlay Autogenous Bone Graft for Treatment of Chronic Mandibular Condylar Dislocation

An interventional study of Patient Specific Titanium Eminoplasty and Inlay Autogenous Bone Graft in Chronic Mandibular Condylar Dislocation, sponsored by Cairo University. Status unknown. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-11-02.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2018), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

In the small and highly specialized field of TMJ surgical treatments, restriction of the mandibular condylar movement outside of the articular eminence is one of the treatment choices suggested in TMJ dislocation.

Limitation of translation of the condyle in TMJ dislocation by inlay autogenous bone graft is the classic method to hinder the movement of the condyle beyond the articular eminence.

Patient specific TMJ prosthesis is very promising nowadays that it will not only build on the strengths of the current TMJ systems but will take advantage of digital innovations in custom design and three-dimensional(3D) printing of TMJ prosthesis. Moreover, TMJ Titanium eminoloplasty was reported to be a predictable and flexible instrument for TMJ dislocation treatment.

Thus, the investigators are conducting this study to compare the effect of both methods on the improvement of the maximal incisal opening of patients with chronic mandibular condylar dislocation, aiming to solve the problem of increasing the mouth opening of patients in their daily mouth opening. Also to reduce the community's fear from such a problem, which sometimes prevent patients from seeking treatment at their dentists leading to more serious complications that can be avoided. Furthermore, the investigators are trying to provide an evidence for oral and maxillofacial surgeons in order to provide the best quality service with the least expenses and thus gaining the patients' trust and saving time, money and effort.

02

Conditions studied

  • Chronic Mandibular Condylar Dislocation

Browse trials for

03

In context

Joint Dislocations

190 studies on the registry are indexed under Joint Dislocations; 39 are open to participants now.

This study's planned enrollment of 12 is below the median of 53 across 120 interventional studies indexed under Joint Dislocations.

Browse Joint Dislocations studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Medically free patients.
  • Long-standing dislocation of the TMJ for more than 3 weeks and the failure of manual reduction.
  • Failure of conservative strategies such as orientation to self-limit jaw movement and the use of a chin-cap or bandage.
  • Previous failed TMJ surgery.
  • Age range is between 18 and 40 years with no sex predilection.
  • Patients who can understand Visual Analogue Scales (VAS) and are able to sign informed consent
  • Highly motivated patients

Exclusion criteria

Exclusion Criteria:

  • Pregnant females.
  • Patients having a significant systemic disorder.
  • Psychological disorders, drug or alcohol dependency.
  • Known allergies or sensitivities to dental materials, including Titanium or general anasethic agents.
  • Severe medical conditions that would not allow management in the clinic.
  • Inability to return for follow up visits.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Patient Specific Titanium Eminoplasty

    * The stages of virtual surgical planning and fabrication of patient specific titanium eminoplasty will be designed my Mimics 15 program. * Once designed, the virtual design and surgery will be planned on a computer model where vital anatomical structures could be identified and thus could be avoided during surgery. * After obtaining all the dataset needed from the CT scan, the collected data will be sent to the Egyptian soil, water and environmental institution for manufacturing, packing and sterilization of the patient specific titanium eminence. * The patient specific titanium eminence will be inserted and secured with two to three screws of individual lengths according to the virtual plan. * Functional mandibular movements were reproduced to confirm absence of subluxation and checked for interference and any required adjustments made. * A multilayer closure of the incisions will be accomplished using Vicryl sutures.

    Device: Patient Specific Titanium Eminoplasty

  • Active comparator
    Inlay Autogenous Bone Graft

    * A safety distance of 5 mm will be maintained from the apex of the mandibular incisor and inferior mandibular border, the mental foramen, and permanent canine follicle. * One corticocancellous bone block with a maximum depth of 4 mm will be removed by mallet and chisel based on the recommendation that bone from the chin should be harvested at this maximum depth, compatible with the course of the mandibular incisive nerve canal on CT scans. * After removal of bone from the chin, the intervening bone struts will be removed using rongeur forceps and used as an additional bone graft. * The bone removed will be trimmed and contoured in a wedge form to be used as an inter-positional graft in the previously down fractured articular eminence to act as an obstacle in front of the mandibular condyle to prevent its hyper movement.

    Procedure: Inlay Autogenous Bone Graft

Interventions

  • DevicePatient Specific Titanium Eminoplasty

    * The stages of virtual surgical planning and fabrication of patient specific titanium eminoplasty will be designed my Mimics 15 program. * Once designed, the virtual design and surgery will be planned on a computer model where vital anatomical structures could be identified and thus could be avoided during surgery. * After obtaining all the dataset needed from the CT scan, the collected data will be sent to the Egyptian soil, water and environmental institution for manufacturing, packing and sterilization of the patient specific titanium eminence. * The patient specific titanium eminence will be inserted and secured with two to three screws of individual lengths according to the virtual plan. * Functional mandibular movements were reproduced to confirm absence of subluxation and checked for interference and any required adjustments made. * A multilayer closure of the incisions will be accomplished using Vicryl

  • ProcedureInlay Autogenous Bone Graft

    \* Steps to harvest the bone graft: * Down-fracture of the articular eminence to be augmented with Inlay bone graft to increase the vertical height of the articular eminence. A green-stick fracture will be created avoiding a possible complete fracture of the lower segment of the eminence * To obtain Inlay bone graft from the chin, anterior mandibular vestibule incision will provide good access to the mandibular symphysis.

06

What researchers measure

Primary outcomes

  1. The maximal incisal opening

    will be measured using a caliper.

    Time frame: 9 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 2, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03728270
Lead sponsor
Cairo University
Responsible party
Rania Ihab Younis (Assistant Lecturer, Cairo University) — Principal investigator
First posted
Nov 2, 2018
Start date
Dec 1, 2018 (estimated)
Primary completion
Dec 1, 2019 (estimated)
Completion
Feb 1, 2020 (estimated)
Last update
Nov 2, 2018

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion